Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
J Cardiovasc Electrophysiol. 2010 May;21(5):521-5. doi: 10.1111/j.1540-8167.2009.01653.x. Epub 2009 Nov 17.
Obesity and obstructive sleep apnea (OSA) have a strong association with atrial fibrillation (AF). The purpose of this study was to prospectively determine the effects of obesity, assessed by the body mass index (BMI) and OSA on the efficacy of catheter ablation of AF.
The patient population consisted of 109 patients (mean age: 60 +/- 10 years, 79% male, 67% paroxysmal, mean BMI 28 +/- 5 kg/m(2)) who underwent catheter ablation of AF. Based on BMI, patients were classified as normal (<25 kg/m(2)), overweight (>or=25 and <30 kg/m(2)), or obese (>or=30 kg/m(2)). OSA was assessed by the Berlin questionnaire. Clinical success was defined as at least 90% reduction in AF burden after 3-month blanking period. Mean duration of follow-up was 11 +/- 4 months.
Of the 75 patients with clinical success, 25 (33%) had normal BMI, 29 (39%) were overweight, and 21 (28%) were obese. Among the 34 patients with failed outcome, 5 (15%) had normal BMI, 14 (41%) were overweight, and 15 (44%) were obese (P = 0.04). Twenty-eight of the 48 patients with OSA (58%) had clinical success as opposed to 47 of the 61 patients (77%) without OSA (P = 0.036). On multivariate analysis, only BMI emerged as an independent predictor of procedural failure ((OR 1.11, CI: 1.00-1.21, P = 0.03).
The results of this prospective study show that obesity, a modifiable risk factor, is an independent predictor of procedural failure after catheter ablation of AF. Whether treating obesity may improve the results of catheter ablation of AF warrants further investigation.
肥胖和阻塞性睡眠呼吸暂停(OSA)与心房颤动(AF)密切相关。本研究的目的是前瞻性地确定肥胖症(通过体重指数(BMI)和 OSA 评估)对 AF 导管消融疗效的影响。
患者人群包括 109 名接受 AF 导管消融的患者(平均年龄:60 +/- 10 岁,79%为男性,67%为阵发性,平均 BMI 为 28 +/- 5 kg/m(2))。根据 BMI,患者被分为正常(<25 kg/m(2))、超重(>=25 且 <30 kg/m(2))或肥胖(>=30 kg/m(2))。OSA 通过柏林问卷进行评估。临床成功定义为在 3 个月空白期后 AF 负担减少至少 90%。平均随访时间为 11 +/- 4 个月。
在 75 名临床成功的患者中,25 名(33%)的 BMI 正常,29 名(39%)超重,21 名(28%)肥胖。在 34 名治疗失败的患者中,5 名(15%)的 BMI 正常,14 名(41%)超重,15 名(44%)肥胖(P = 0.04)。在 48 名患有 OSA 的患者中,有 28 名(58%)临床成功,而在 61 名没有 OSA 的患者中,有 47 名(77%)临床成功(P = 0.036)。多变量分析显示,只有 BMI 是导管消融术失败的独立预测因素(OR 1.11,95%CI:1.00-1.21,P = 0.03)。
这项前瞻性研究的结果表明,肥胖(一种可改变的危险因素)是 AF 导管消融后手术失败的独立预测因素。治疗肥胖症是否可以改善 AF 导管消融的结果,值得进一步研究。